The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b/2 study of surufatinib in combination with docetaxel as second-line treatment of advanced driver-gene negative non-squamous non-small cell lung cancer (NSCLC).
 
Wei Jiang
No Relationships to Disclose
 
Jianbo He
No Relationships to Disclose
 
Ruiling Ning
No Relationships to Disclose
 
Yun Zhao
No Relationships to Disclose
 
Shaozhang Zhou
No Relationships to Disclose
 
Huilin Wang
No Relationships to Disclose
 
Shubin Chen
No Relationships to Disclose
 
Haijie Gan
No Relationships to Disclose
 
Jieqing Lin
No Relationships to Disclose
 
Qitao Yu
No Relationships to Disclose